PET developer Positron of Houston has completed the due diligencephase of its planned acquisition of GE Medical Systems' PET business(SCAN 7/31/96). Positron said it is in the latter stages of securingfinancing for the deal, which it expects to have in
PET developer Positron of Houston has completed the due diligencephase of its planned acquisition of GE Medical Systems' PET business(SCAN 7/31/96). Positron said it is in the latter stages of securingfinancing for the deal, which it expects to have in place in fourto six weeks. The company said it hopes to close the deal by theend of this year, after shareholder approval is received.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.